Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 4906 AL 4920

Exosome Cargo in Neurodegenerative Diseases: Leveraging Their Intercellular Communication Capabilities for Biomarker Discovery and Therapeutic Delivery

Zhang S, Yang Y, Lv X, Zhou X, Zhao W, Meng L, Zhu S, Zhang Z, Wang Y.

Brain Sci. 2024 Oct 23;14(11):1049. doi: 10.3390/brainsci14111049.

Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review

Izadi R, Bahramikia S, Akbari V.

Front Neurosci. 2024 Nov 22;18:1453499. doi: 10.3389/fnins.2024.1453499. eCollection 2024.

The importance of choosing the appropriate cholesterol quantification method: enzymatic assay versus gas chromatography

Serrano J, Martine L, Grosjean Y, Acar N, Alves G, Masson EAY.

J Lipid Res. 2024 Jun;65(6):100561. doi: 10.1016/j.jlr.2024.100561. Epub 2024 May 17.

Prevalence of Juvenile-Onset and Pediatric Huntington's Disease and Their Availability and Ability to Participate in Trials: A Dutch Population and Enroll-HD Observational Study

Bakels HS, Feleus S, Rodríguez-Girondo M, Losekoot M, Bijlsma EK, Roos RAC, de Bot ST.

J Huntingtons Dis. 2024;13(3):357-368. doi: 10.3233/JHD-240034.

Transposable element small and long RNAs in aging brains and implications in Huntington's and Parkinson's disease

Dayama G, Gupta S, Connizzo BK, Labadorf AT, Myers RH, Lau NC.

bioRxiv [Preprint]. 2024 Oct 25:2024.10.22.619758. doi: 10.1101/2024.10.22.619758.

An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease

McGarry A, Hunter K, Gaughan J, Auinger P, Ferraro TN, Pradhan B, Ferrucci L, Egan JM, Moaddel R.

Sci Rep. 2024 Jan 11;14(1):1101. doi: 10.1038/s41598-023-50553-y.

Clinical Reasoning and Challenges Faced With Onset Psychotic Symptoms in a Case of Combined Huntington's Disease and Gayet-Wernicke Encephalopathy

Omri M, Ferhi M, Oliveira Galvao M, Hamm O.

Cureus. 2024 Jun 7;16(6):e61875. doi: 10.7759/cureus.61875. eCollection 2024 Jun.

The psychometric properties of the Quality of Life in Neurological Disorders (Neuro-QoL) measurement system in neurorehabilitation populations: a systematic review

Ataman R, Alhasani R, Auneau-Enjalbert L, Quigley A, Michael HU, Ahmed S.

J Patient Rep Outcomes. 2024 Sep 18;8(1):106. doi: 10.1186/s41687-024-00743-7.

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid

López-Sánchez C, Lagoa R, Poejo J, García-López V, García-Martínez V, Gutierrez-Merino C.

Molecules. 2024 Feb 8;29(4):776. doi: 10.3390/molecules29040776.

Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models

Hanrahan J, Locke DP, Cahill LS.

J Huntingtons Dis. 2024;13(3):279-299. doi: 10.3233/JHD-240045.

Chorea Associated with Notch3 Gene Mutation

Salari M, Rezaei K, Rashedi R, Etemadifar M.

Mov Disord Clin Pract. 2024 Jul;11(7):902-904. doi: 10.1002/mdc3.14053. Epub 2024 May 13.

Assessment of Fitbit Charge 4 for sleep stage and heart rate monitoring against polysomnography and during home monitoring in Huntington's disease

Doheny EP, Renerts K, Braun A, Werth E, Baumann C, Baumgartner P, Morgan-Jones P, Busse M, Lowery MM, Jung HH.

J Clin Sleep Med. 2024 Jul 1;20(7):1163-1171. doi: 10.5664/jcsm.11098.

Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders

Sethiya NK, Ghiloria N, Srivastav A, Bisht D, Chaudhary SK, Walia V, Alam MS.

CNS Neurol Disord Drug Targets. 2024;23(7):865-882. doi: 10.2174/1871527322666230718105358.

Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation

Solem MA, Pelzel R, Rozema NB, Brown TG, Reid E, Mansky RH, Gomez-Pastor R.

bioRxiv [Preprint]. 2024 Oct 16:2024.10.14.618355. doi: 10.1101/2024.10.14.618355.

Research advances in huntingtin-associated protein 1 and its application prospects in diseases

Wu Y, Wang Y, Lu Y, Yan J, Zhao H, Yang R, Pan J.

Front Neurosci. 2024 Jun 21;18:1402996. doi: 10.3389/fnins.2024.1402996. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias